STRATA CRITICAL MEDICAL, INC. Depreciation
STRATA CRITICAL MEDICAL, INC. (SRTA) reported Depreciation of $1.89 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-04
- STRATA CRITICAL MEDICAL, INC. depreciation for the quarter ending 2026-06-30 was $1.89M, a 117.76% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. depreciation for the quarter ending 2026-03-31 was $1.57M, a 92.89% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. depreciation for the quarter ending 2025-12-31 was $1.53M, a 97.42% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. depreciation for the quarter ending 2025-09-30 was $1.08M, a 93.73% increase year-over-year.
- STRATA CRITICAL MEDICAL, INC. depreciation for fiscal 2025 was $4.30M, a 114.80% increase from fiscal 2024.
- STRATA CRITICAL MEDICAL, INC. depreciation for fiscal 2024 was $2.00M, a 86.05% increase from fiscal 2023.
- STRATA CRITICAL MEDICAL, INC. depreciation for fiscal 2023 was $1.07M, a 29.52% increase from fiscal 2022.
- STRATA CRITICAL MEDICAL, INC. depreciation for fiscal 2022 was $830.00K.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.89M 10-Q · filed 2026-08-04 | $3.46M 10-Q · filed 2026-08-04 | $4.99M derived: sum of 3 quarters · filed 2026-08-04 | $6.08M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-31 | $1.57M 10-Q · filed 2026-05-06 | $3.11M derived: sum of 2 quarters · filed 2026-05-06 | $4.19M derived: sum of 3 quarters · filed 2026-05-06 | $5.05M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $2.61M derived: sum of 2 quarters · filed 2026-03-03 | $3.48M derived: sum of 3 quarters · filed 2026-08-04 | $4.30M 10-K · filed 2026-03-03 | ||||
| 2025-09-30 | $1.08M 10-Q · filed 2025-11-10 | $1.95M derived: sum of 2 quarters · filed 2026-08-04 | $2.76M 10-Q · filed 2025-11-10 | $3.54M derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-30 | $867.00K 10-Q · filed 2026-08-04 | $1.08M 10-Q · filed 2025-08-05 | $1.68M 10-Q · filed 2026-08-04 | $2.12M 10-Q · filed 2025-08-05 | $2.46M derived: sum of 3 quarters · filed 2026-08-04 | $3.02M derived: sum of 4 quarters · filed 2026-08-04 | ||
| 2025-03-31 | $816.00K 10-Q · filed 2026-05-06 | $1.03M 10-Q · filed 2025-05-12 | $1.59M derived: sum of 2 quarters · filed 2026-05-06 | $2.15M derived: sum of 3 quarters · filed 2026-05-06 | $2.81M derived: sum of 4 quarters · filed 2026-05-06 | |||
| 2024-12-31 | $776.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $1.33M derived: sum of 2 quarters · filed 2026-03-03 | $2.00M derived: sum of 3 quarters · filed 2026-03-03 | $2.00M 10-K · filed 2026-03-03 | $2.98M 10-K · filed 2025-03-13 | |||
| 2024-09-30 | $558.00K 10-Q · filed 2025-11-10 | $815.00K 10-Q · filed 2024-11-12 | $1.22M derived: sum of 2 quarters · filed 2025-11-10 | $1.22M 10-Q · filed 2025-11-10 | $2.00M 10-Q · filed 2024-11-12 | $2.02M derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | $663.00K 10-Q · filed 2025-08-05 | $1.19M 10-Q · filed 2025-08-05 | $1.46M derived: sum of 3 quarters · filed 2025-08-05 | $1.76M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $525.00K 10-Q · filed 2025-05-12 | $798.00K derived: sum of 2 quarters · filed 2025-05-12 | $1.10M derived: sum of 3 quarters · filed 2025-05-12 | $1.36M derived: sum of 4 quarters · filed 2025-05-12 | ||||
| 2023-12-31 | $273.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $575.00K derived: sum of 2 quarters · filed 2025-03-13 | $835.00K derived: sum of 3 quarters · filed 2025-03-13 | $1.07M 10-K · filed 2025-03-13 | ||||
| 2023-09-30 | $302.00K 10-Q · filed 2024-11-12 | $562.00K derived: sum of 2 quarters · filed 2024-11-12 | $802.00K 10-Q · filed 2024-11-12 | |||||
| 2023-06-30 | $260.00K 10-Q · filed 2024-08-08 | $500.00K 10-Q · filed 2024-08-08 | ||||||
| 2022-12-31 | $830.00K 10-K · filed 2023-03-16 | |||||||
| 2022-03-31 | $148.00K 10-Q · filed 2022-05-10 | $285.00K derived: sum of 2 quarters · filed 2023-03-16 | ||||||
| 2021-12-31 | $137.00K 10-K · filed 2023-03-16 | |||||||
| 2021-09-30 | $830.00K 10-K · filed 2024-03-12 | $353.00K 10-K · filed 2021-12-20 | ||||||
| 2021-03-31 | $79.00K 10-Q · filed 2022-05-10 | $171.00K derived: sum of 2 quarters · filed 2023-01-10 | ||||||
| 2020-12-31 | $92.00K 8-K · filed 2023-01-10 | |||||||
| 2020-09-30 | $336.00K 10-K · filed 2021-12-20 | |||||||
| 2019-09-30 | $289.00K 10-K · filed 2021-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |